The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer - Test2 - elhamkhani - TriplyDB

The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer

The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer

http://www.wikidata.org/entity/Q28253300

about

Deubiquitylating enzymes and disease Genome-wide linkage and association analyses implicate FASN in predisposition to Uterine Leiomyomata The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2 Suppression of cancer cell growth by promoting cyclin D1 degradation MdmX is a substrate for the deubiquitinating enzyme USP2a O-GlcNAcylation and the Metabolic Shift in High-Proliferating Cells: All the Evidence Suggests that Sugars Dictate the Flux of Lipid Biogenesis in Tumor Processes The potential of ¹¹C-acetate PET for monitoring the Fatty acid synthesis pathway in Tumors Lipid metabolism in prostate cancer USP2-45 Is a Circadian Clock Output Effector Regulating Calcium Absorption at the Post-Translational Level A synthetic form of frizzled 8-associated antiproliferative factor enhances p53 stability through USP2a and MDM2 De novo fatty acid biosynthesis contributes significantly to establishment of a bioenergetically favorable environment for vaccinia virus infection Blockade of fatty acid synthase triggers significant apoptosis in mantle cell lymphoma Regulator of fatty acid metabolism, acetyl coenzyme a carboxylase 1, controls T cell immunity.Screen for ISG15-crossreactive deubiquitinases.Hepatocyte RXRalpha deficiency in matured and aged mice: impact on the expression of cancer-related hepatic genes in a gender-specific manner Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer.Fatty acid synthase reprograms the epigenome in uterine leiomyosarcomas.Ubiquitin-specific cysteine protease 2a (USP2a) regulates the stability of Aurora-A.The de-ubiquitinylating enzyme, USP2, is associated with the circadian clockwork and regulates its sensitivity to light.Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker.HO-3867, a synthetic compound, inhibits the migration and invasion of ovarian carcinoma cells through downregulation of fatty acid synthase and focal adhesion kinase.Ubiquitin-specific protease 2-45 (Usp2-45) binds to epithelial Na+ channel (ENaC)-ubiquitylating enzyme Nedd4-2.The pathogenesis of prostate cancer: from molecular to metabolic alterations.Molecular pathways and targets in prostate cancer ABRO1 suppresses tumourigenesis and regulates the DNA damage response by stabilizing p53.Midkine, a heparin-binding protein, is increased in the diabetic mouse kidney postmenopause.Ubiquitin becomes ubiquitous in cancer: emerging roles of ubiquitin ligases and deubiquitinases in tumorigenesis and as therapeutic targets.Discovery of putative oocyte quality markers by comparative ExacTag proteomics Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.Alpha-lipoic acid reduces LDL-particle number and PCSK9 concentrations in high-fat fed obese Zucker rats.Control of AIF-mediated cell death by antagonistic functions of CHIP ubiquitin E3 ligase and USP2 deubiquitinating enzyme.Reduced association of anti-apoptotic protein Mcl-1 with E3 ligase Mule increases the stability of Mcl-1 in breast cancer cells.Screening of DUB activity and specificity by MALDI-TOF mass spectrometry Cancer cells differentially activate and thrive on de novo lipid synthesis pathways in a low-lipid environment.Roles of ubiquitination and SUMOylation on prostate cancer: mechanisms and clinical implications.Metabolic alterations and targeted therapies in prostate cancer.Fatty acid synthase as a potential therapeutic target in cancer.Ubiquitin-specific protease 2 regulates hepatic gluconeogenesis and diurnal glucose metabolism through 11β-hydroxysteroid dehydrogenase 1 The ubiquitin-specific protease USP2a enhances tumor progression by targeting cyclin A1 in bladder cancer.Complementary Cholesterol-Lowering Response of a Phytosterol/α-Lipoic Acid Combination in Obese Zucker Rats.

P2860

Q21284381-AC31B1F7-35C1-491E-8427-F773C182F90C Q21710707-9574DA91-3602-4990-B3D9-829439E6280E Q24296502-B9178720-264F-41CC-833F-5F68E808AE42 Q24317660-A9806F47-510F-4496-8BBA-634EA21531BD Q24336863-E17A8A33-6269-4998-9A5F-5F2115611DA7 Q26770270-EE5CA08D-356A-44CA-8067-929632EEB306 Q26996477-A573DE53-F56C-4EA2-997D-9B76B5DE5B64 Q27025766-BEB840FE-2B57-4739-9BA3-50F77239D78B Q27334789-0A9C2B28-1D78-495E-AD10-31432032F327 Q28485503-52E2995B-D2D8-43A4-B734-292C5110453C Q28541249-1CB1EF3D-37DE-49F6-B918-2151BF41BE00 Q28730808-EDC3ACA2-DF68-4BC5-9382-F7369672CBA7 Q30406101-4726A88C-5662-451B-871A-C051329498E5 Q33291767-DB29A913-645A-4900-8BFE-F96E017E0A17 Q33364577-71033EA4-DBED-44BF-BF21-69B0AF385991 Q33421665-EDFB5097-7204-41DC-8AFB-CDF7A525D63F Q33842260-FB1FBA2C-E30A-4758-9504-14B952E831A5 Q34010768-B63F42D1-1A9C-487E-BED7-5D10C11C7A25 Q34038295-FBA84E47-940A-4D48-A262-3AB47F5EC0E3 Q34058540-9EE55B1A-351D-4EFC-941C-62BB8579DBCC Q34139276-AEB8D2F8-597C-4D64-8C96-4143BA7673CF Q34177064-0D0F1CE4-F7EB-4E71-BDA1-681252BBBE21 Q34201846-E7159A84-B17A-4D9F-AD94-2A6E11020118 Q34365632-42D1DBDE-26BD-491E-84F5-27723EC67D3E Q34385189-0D5FC2B0-4085-4463-873E-157F32AB6E7B Q34501860-0C0AB5A2-A945-472F-8AFD-7474D1FA56FA Q34503492-E8022E11-4677-4F51-964B-B0E6B32E9164 Q34581478-32C5220A-65CD-4D64-9642-B445CF1D301B Q34672477-088C2B35-1F07-48ED-8244-06682AA3E8B2 Q35111400-86619626-E16B-4B38-8377-F9F86AE61546 Q35210599-E5679D21-0E5B-4192-850E-EB117C963097 Q35212637-029FE8DF-7EB0-4315-A31D-A8C1A79A3C7D Q35232335-40D0D595-5DB3-4E8C-8EF3-251FD19EF8F5 Q35249792-0ADAF854-35FD-4EF5-83AC-08BDB97DEEED Q35380380-D9572FFF-94C1-4764-9444-6BE3E0DDFBF9 Q35401667-4EBDA7A0-6A18-4979-86EE-2F6CD6BD518B Q35401716-BBD4B96A-14FC-4EBA-9A8B-21D1011B485F Q35902915-D0C95B37-BC5E-4E6D-A768-49F7E9B2076D Q35911159-46CBD380-6FB1-494A-AADE-8E0E27DB640E Q35931637-EFEE90E8-64B4-4A98-B0F5-6C8E396EC563

P2860

The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer

http://www.wikidata.org/entity/Q28253300

description

2004 nî lūn-bûn

@nan

2004 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի մարտին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer

@ast

The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer

@en

The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer

@nl

type

label

The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer

@ast

The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer

@en

The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer

@nl

prefLabel

The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer

@ast

The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer

@en

The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer

@nl

P1433

Q28253300-BBB5D7A9-CDC2-40B1-9CFA-D2CE269BC5EB

P1476

Q28253300-01EDECA4-0C0E-4FDA-91DC-E2BF6BD6B53F

P2093

Q28253300-409D6EC2-6997-4A2E-8225-7A34622B887F

Q28253300-41C8E368-F94E-4EE3-85D4-FE572AB93C12

Q28253300-6BD71CA8-5046-48CA-B281-16203726A124

Q28253300-6D6B23FE-730D-409A-82E5-DF9488E92ECE

Q28253300-7BF18EDC-FC28-4828-BBB7-D956543E3257

Q28253300-960CC3DB-3BEB-45EE-A833-5EFA818B8B89

Q28253300-C7364D18-0F95-4879-AFB4-37D9C4993D95

Q28253300-E9CB656D-A3C0-4954-B114-E1FFE7D1EDEE

Q28253300-F0FC925C-643A-4811-85F2-85116DDFAE48

Q28253300-FD527476-2706-4CF3-B242-ECDA6FA3AE60

P304

Q28253300-AF7F1245-8B7C-4922-A454-3FDE3F11B12B

P31

Q28253300-FEBC7794-6B72-4799-A911-28A45D673DC2

P3181

Q28253300-2851E6FB-265A-4449-9799-16C682A22AF4

P356

Q28253300-744AE0C4-2BE1-41AE-A05B-CBA3FE429DDF

P407

Q28253300-EE5FEB32-EC72-48B2-83C8-BC6ABA3631E7

P433

Q28253300-A52BC359-1305-4516-9A1D-5BB5F5B910EF

P478

Q28253300-0DADB73B-C328-41FE-A7C1-639B2AFAD987

P50

Q28253300-BADFC17D-D8BA-44E0-8BC3-210AA4E61F88

P577

Q28253300-D0819C31-CA2F-44C4-A5C2-11AC97781F5F

P5875

Q28253300-187D71BA-74CD-41C5-87EC-AAB25F736369

P698

Q28253300-087DEBF7-CD93-4F32-A6D0-2671F08F0016

P921

Q28253300-F245332F-38A3-4ABC-A585-3F98F3D42A0F

P3181

P356

S1535-6108(04)00055-8

P1433

P1476

The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer

@en

P2093

Antonella Baron

http://www.w3.org/2001/XMLSchema#string

Dan Tang

http://www.w3.org/2001/XMLSchema#string

Dieter Huesken

http://www.w3.org/2001/XMLSchema#string

Edgard Graner

http://www.w3.org/2001/XMLSchema#string

Johann Zimmermann

http://www.w3.org/2001/XMLSchema#string

Lisa J Weinstein

http://www.w3.org/2001/XMLSchema#string

Mirna Lechpammer

http://www.w3.org/2001/XMLSchema#string

Sabina Signoretti

http://www.w3.org/2001/XMLSchema#string

Sabrina Rossi

http://www.w3.org/2001/XMLSchema#string

Toshiro Migita

http://www.w3.org/2001/XMLSchema#string

P304

253-61

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3861513

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/S1535-6108(04)00055-8

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8649895

http://www.w3.org/2001/XMLSchema#string

P698

15050917

http://www.w3.org/2001/XMLSchema#string

P921